作者:
Cong,H. [1]
;
Mui,E.J. [2]
;
Witola,W.H. [3]
;
Sidney,J. [4]
;
Alexander,J. [5]
;
Sette,A. [6]
;
Maewal,A. [7]
;
ElBissati,K. [8]
;
Zhou,Y. [9]
;
Suzuki,Y. [10]
;
Lee,D. [11]
;
Woods,S. ;
Sommerville,C. ;
Henriquez,F.L. ;
Roberts,C.W. ;
McLeod,R.
作者单位:
Department of Immunology and Microbiology, University of Kentucky, Lexington, KY 40526, United
[1]
Department of Surgery, The University of Chicago, Chicago, IL 60637, United States, Strathclyde
[2]
Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037
[3]
Synthetic Biomolecules, San Diego, CA 92121, United States
[4]
Strathclyde Institute of Pharmacy and Biomedical Science, University of Strathclyde, Glasgow
[5]
Pharmexa-Epimmune, San Diego, CA 92121, United States, PaxVax, 3985A Sorrento Valley Boulevard, San
[6]
School of Science, University of the West of Scotland, Paisley, Scotland, United Kingdom
[7]
Pharmexa-Epimmune, San Diego, CA 92121, United States
[8]
Departments of Surgery (Ophthalmology) and Pediatrics (Infectious Disease), Committees on
[9]
Department of Surgery, The University of Chicago, Chicago, IL 60637, United States, Department of
[10]
Department of Surgery, The University of Chicago, Chicago, IL 60637, United States
[11]
发布时间
2013-11-20